CannabisNewsBreaks

TuesdayMay 16, 2017 10:37 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adds Craig Cheifetz, M.D. to Advisory Team

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that Craig Cheifetz, M.D. has joined the company as an advisor to provide guidance on clinical trials, biotechnology, neuroscience, immunology and microbiology. “I welcome Dr. Cheifetz to the IGC advisory team and look forward to his contributions as we move forward in developing cannabis-based, combination therapies,” Ram Mukunda, CEO of IGC, stated in the news release. “We remain committed to accelerating our initiatives and building a robust portfolio of compounds to address large market conditions.” Cheifetz currently serves…

Continue Reading

FridayMay 12, 2017 12:07 pm

CannabisNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Acquisition Strategy in Interview on MoneyTV

Specialized holding company SinglePoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, SinglePoint CEO Greg Lambrecht discusses the company’s progress toward expanding its presence in the burgeoning legal marijuana industry by way of acquisition. “We’ve spent the last couple of months courting companies to acquire them, particularly in the cannabis space,” Lambrecht noted in the interview. “Actually, I think next week we’re going to be putting an LOI…

Continue Reading

ThursdayMay 11, 2017 11:09 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Pursues Continued Success in CBD Markets

Leveraging its achievements of amassing a 100,000+ user base, establishing a recognizable 18-year-old brand, and sharpening its focus on a market that exceeds two billion Chinese-speaking individuals, ChineseInvestors.com (OTCQB: CIIX) has reached a first-in-the-marketplace milestone by launching the world’s first and only Chinese language, cannabinoid-based therapeutic health products web store, http://www.ChineseCBDoil.com. After making a successful investment in the marijuana market, the company recently expanded into the retail and online sale of cannabidiol (CBD), which has become one of the fastest-growing market categories in the United States. “With an annual growth rate of nearly 60 percent, CBD oil has become one…

Continue Reading

ThursdayMay 11, 2017 11:07 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Poised to Become Phytocannabinoid Pharmaceuticals Leader

At its recent 70th annual meeting, the American Epilepsy Society (AES) highlighted a study focusing on the potential of cannabidiol (CBD) to treat the frequency and severity of seizures in children who have drug-resistant epilepsies. India Globalization Capital (NYSE MKT: IGC), an innovator in developing cannabis-based combination therapies to treat pain and other conditions, is currently applying the revolutionary seizure-treating potential of CBD to another population: domestic pets, and the company is addressing the 5 percent of dogs and just over 2 percent of cats in the United States that experience seizures. “Cannabidiol is the most abundant non-psychoactive cannabinoid found…

Continue Reading

WednesdayMay 10, 2017 1:58 pm

CannabisNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Extends Role of “Father of Marijuana Research” Raphael Mechoulam

In a news release issued early Tuesday, ABcann Global Corporation (TSXV: ABCN) announced that Raphael Mechoulam has agreed to extend his role as an advisor to the company. Aaron Keay, CEO and director of ABcann, spoke to the importance of this agreement in the news release. “Professor Mechoulam’s experience in medicinal cannabis is an invaluable resource for ABcann as we enter the most aggressive growth stage in the company’s history,” he stated. “The Company has invested heavily to build and extend its early leadership in advanced pharmaceutical-grade cannabis production. Professor Mechoulam’s advice, guidance, and unmatched expertise in the field has…

Continue Reading

WednesdayMay 10, 2017 9:39 am

CannabisNewsBreaks – InMed Pharmaceuticals (IMLFF) Announces Filing of Provisional Patent for INM-085

Pre-clinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) (CSE: IN) this morning announced the filing of a provisional patent application in the United States for INM-085 as a cannabinoid-based topical therapy for glaucoma. The company notes that this move marks an important step toward providing intellectual and commercial protection for INM-085. If approved, INM-085 could address an expansive global market that’s currently valued in excess of $5 billion. Per this morning’s update, glaucoma is currently the second-leading cause of blindness, driven by risk factors such as increased pressure in the eye, a family history of the condition, migraines, high…

Continue Reading

TuesdayMay 09, 2017 12:52 pm

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Announces Launch of Expanded Shareholder Communications Campaign

Diversified holding company Player’s Network, Inc. (OTCQB: PNTV) today announced the launch of a new, expanded shareholder communications and investor relations campaign aimed at broadening the company’s visibility in the investment community and providing added transparency to its shareholders by offering insight into all current operations and future plans. Introduction of the new campaign follows a significant spike in shareholder inquiries related to PNTV’s transition from developmental-stage holdings into operational, particularly as it relates to the company’s entry into the booming legal marijuana industry. “We have spent the last few months obsessing over revolutionary methods to better communicate with our…

Continue Reading

TuesdayMay 09, 2017 9:16 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Set to Begin Onboarding ‘High Risk’ Merchant Accounts

Specialized holding company Singlepoint, Inc. (OTC: SING) this morning announced its entry into a new agreement enabling the company to start onboarding ‘high risk’ merchant accounts. “We are providing multiple solutions to the cannabis space and we are trying to do the same in the payments space as well,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “Being able to offer a payment solution to multiple different verticals gives the company a larger target market to tap into. We believe high risk is a huge opportunity and an underserved market at this point.” The new solution will offer…

Continue Reading

FridayMay 05, 2017 12:18 pm

CannabisNewsBreaks – Eco Science Solutions, Inc. (ESSI) Inks LOI to Acquire Specialty Banking Operation; Shares Rise

Eco Science Solutions, Inc. (OTCQB: ESSI) shares are up more than 18% after the company this morning said it has signed a Letter of Intent (LOI) with Ga-Du Bank, Inc. for the purpose of acquiring full ownership of the bank in a stock and cash transaction. ESSI will operate the bank as a wholly owned subsidiary upon the closing of the transaction. Furthermore, the company will operate the financial banking division providing payment processing, cash management and financial services to its customers in the cannabis industry. "It has been our vision from day one that, in order to fully service…

Continue Reading

FridayMay 05, 2017 11:10 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses “State of the Company” in Interview on MoneyTV

Specialized holding company Singlepoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the ‘State of the Company’, giving prospective shareholders some additional insight into the forward plans of both SinglePoint and its SingleSeed subsidiary. “We’re continuing to stick to our plan – that is to raise funds, acquire companies and get more products that we can sell to dispensaries,” Lambrecht noted in the…

Continue Reading